TY - JOUR
T1 - Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy
T2 - an Ethics Committee opinion
AU - Daar, Judith
AU - Benward, Jean
AU - Collins, Lee Rubin
AU - Davis, Joseph
AU - Francis, Leslie
AU - Gates, Elena
AU - Ginsburg, Elizabeth
AU - Koenig, Barbara
AU - La Barbera, Andrew
AU - McCullough, Laurence
AU - Reindollar, Richard
AU - Sauer, Mark
AU - Klipstein, Sigal
AU - Sokol, Rebecca
AU - Tipton, Sean
AU - Westphal, Lynn
N1 - Publisher Copyright:
© 2016 American Society for Reproductive Medicine
PY - 2016/11/1
Y1 - 2016/11/1
N2 - This opinion addresses the ethics of providing fertility treatment to women at elevated risk from fertility treatment or pregnancy. Providers ethically may treat women at elevated risk provided that they are carefully assessed; that specialists in their medical condition are consulted as appropriate; and that patients are fully informed about risks, benefits, and alternatives, including oocyte and embryo donation, use of a gestational surrogate, not undergoing fertility care, and adoption. Providers also may conclude that the risks are too high for them to treat particular patients ethically; such determinations must be made in a medically objective and unbiased manner and patients must be fully informed of the decision. Counseling of women who wish to initiate fertility treatment with underlying medical conditions that confer increased risk during treatment or pregnancy should incorporate the most current knowledge available, being cognizant of the woman's personal determinants in relation to her reproductive desires. In such a way, both physician and patient will optimize decision making in an ethically sound, patient-supportive context.
AB - This opinion addresses the ethics of providing fertility treatment to women at elevated risk from fertility treatment or pregnancy. Providers ethically may treat women at elevated risk provided that they are carefully assessed; that specialists in their medical condition are consulted as appropriate; and that patients are fully informed about risks, benefits, and alternatives, including oocyte and embryo donation, use of a gestational surrogate, not undergoing fertility care, and adoption. Providers also may conclude that the risks are too high for them to treat particular patients ethically; such determinations must be made in a medically objective and unbiased manner and patients must be fully informed of the decision. Counseling of women who wish to initiate fertility treatment with underlying medical conditions that confer increased risk during treatment or pregnancy should incorporate the most current knowledge available, being cognizant of the woman's personal determinants in relation to her reproductive desires. In such a way, both physician and patient will optimize decision making in an ethically sound, patient-supportive context.
KW - Fertility treatment
KW - assisted reproductive technology
KW - complications
KW - ethics
KW - high risk pregnancy
UR - https://www.scopus.com/pages/publications/84994157067
U2 - 10.1016/j.fertnstert.2016.08.015
DO - 10.1016/j.fertnstert.2016.08.015
M3 - Article
C2 - 27530060
AN - SCOPUS:84994157067
SN - 0015-0282
VL - 106
SP - 1319
EP - 1323
JO - Fertility and Sterility
JF - Fertility and Sterility
IS - 6
ER -